New Market Research Report: Serbia Pharmaceuticals & Healthcare Report Q4 2014
In July, Serbia's National Health Insurance Fund (RFZO) cut medicine prices by around 50% through a new policy, pravda.rs reported , citing Momcilo Babic, RFZO's d irector. Although criticised by the media for its new policy of lowering medicine prices, Babic believes it means that the organisation is not working for pharmaceutical companies but for the benefit of the Serbian people. The implementation of the government's new regulation on medicine prices in the country will lead to considerable savings. This...
View full press release